OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Inspiratory Capacity Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 272 reports · 32 co-occurring drugs

As of the last recalculation, Inspiratory Capacity Decreased appears in 272 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is PHENYTOIN (PRR 552.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Phenytoin97552.3554.9
Human Immunoglobulin G74376.7378.0
Bupivacaine36339.7341.0
Tranexamic Acid26247.2248.0
Chlorhexidine Gluconate25230.5231.1
Hydrocortisone Sodium Succinate25224.0224.6
Lidocaine Hydrochloride And Epinephrine Bitartrate93202.1202.5
Lidocaine Hydrochloride99197.0197.4
Cefazolin Sodium27190.2190.6
Lidicaine84189.6189.9
Burn Relief84189.6189.9
Lidocaine Hydrochloride And Epinephrine84189.3189.7
Lidocaine, Menthol84187.1187.4
Rocuronium Bromide26186.6187.0
Diclofenac Sodium 1%62171.7172.0
Diclofenac Sodium Topical62171.7172.0
Diclofenac Sodium Topical Gel, 1%62171.4171.7
Venlafaxine101171.1171.3
Lidocaine 4%84170.2170.5
Lidocaine84159.0159.2
Norepinephrine Bitartrate26152.7153.0
Diclofenac95129.2129.3
Hydromorphone Hydrochloride95120.9121.0
Fentanyl99120.4120.5
Olanzapine98108.5108.6
Venlafaxine Hydrochloride10192.392.4
Diclofenac Sodium9674.974.9
Propofol2660.160.2
Mepolizumab2338.638.6
Fluticasone Furoate And Vilanterol Trifenatate1636.136.1
Diclofenac Potassium, Film Coated327.627.6
Diclofenac Potassium Tablets327.627.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.